Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians 71:209–249
Land L, Dalton S, Jensen M et al (2012) Influence of comorbidity on the effect of adjuvant treatment and age in patients with early-stage breast cancer. Br J Cancer 107:1901–1907
Article CAS PubMed PubMed Central Google Scholar
Mehta LS, Watson KE, Barac A et al (2018) Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American Heart Association. Circulation 137:e30–e66
Article PubMed PubMed Central Google Scholar
Ministry of Health (2019) Annual Update of Key Results 2018/19: New Zealand Health Survey. Ministry of Health, Wellington
Ford ES, Li C, Zhao G et al (2010) Trends in low-risk lifestyle factors among adults in the United States: findings from the Behavioral Risk Factor Surveillance System 1996–2007. Prev Med 51:403–407
Feingold KR (2021) Cholesterol lowering drugs. Endotext
Baigent C, Keech A, Kearney PM et al (2005) Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins. Lancet 366:1267–1278
Article CAS PubMed Google Scholar
Ehmsen S, Pedersen MH, Wang G et al (2019) Increased cholesterol biosynthesis is a key characteristic of breast cancer stem cells influencing patient outcome. Cell Rep 27(3927–3938):e6
Borgquist S, Djerbi S, Pontén F et al (2008) HMG-CoA reductase expression in breast cancer is associated with a less aggressive phenotype and influenced by anthropometric factors. Int J Cancer 123:1146–1153
Article CAS PubMed Google Scholar
Beckwitt CH, Brufsky A, Oltvai ZN et al (2018) Statin drugs to reduce breast cancer recurrence and mortality. Breast Cancer Res 20:1–11
Blanco-Colio LM, Tuñón J, Martín-Ventura JL et al (2003) Anti-inflammatory and immunomodulatory effects of statins. Kidney Int 63:12–23
Article CAS PubMed Google Scholar
Bellosta S, Bernini F, Paoletti R et al (2000) Non-lipid-related effects of statins. Ann Med 32:164–176
Article CAS PubMed Google Scholar
Beckwitt CH, Clark AM, Ma B et al (2018) Statins attenuate outgrowth of breast cancer metastases. Br J Cancer 119:1094–1105
Article CAS PubMed PubMed Central Google Scholar
Ghosh-Choudhury N, Mandal CC, Ghosh-Choudhury N et al (2010) Simvastatin induces derepression of PTEN expression via NFκB to inhibit breast cancer cell growth. Cell Signal 22:749–758
Article CAS PubMed PubMed Central Google Scholar
Campbell MJ, Esserman LJ, Zhou Y et al (2006) Breast cancer growth prevention by statins. Can Res 66:8707–8714
Borgquist S, Broberg P, Tojjar J et al (2019) Statin use and breast cancer survival–a Swedish nationwide study. BMC Cancer 19:1–9
Smith A, Murphy L, Zgaga L et al (2017) Pre-diagnostic statin use, lymph node status and mortality in women with stages I-III breast cancer. Br J Cancer 117:588–596
Article CAS PubMed PubMed Central Google Scholar
Murtola TJ, Visvanathan K, Artama M et al (2014) Statin use and breast cancer survival: a nationwide cohort study from Finland. PLoS ONE 9:e110231
Article PubMed PubMed Central Google Scholar
Hosio M, Urpilainen E, Hautakoski A, Marttila M, Arffman M, Sund R, Ahtikoski A, Puistola U, Karihtala P, Jukkola A, Läärä E (2020) Survival after breast cancer in women with type 2 diabetes using antidiabetic medication and statins: a retrospective cohort study. Acta Oncologica 59(9):1110–1117
Nowakowska MK, Lei X, Thompson MT et al (2021) Association of statin use with clinical outcomes in patients with triple-negative breast cancer. Cancer 127:4142–4150
Article CAS PubMed Google Scholar
Nielsen SF, Nordestgaard BG, Bojesen SE (2012) Statin use and reduced cancer-related mortality. N Engl J Med 367:1792–1802
Article CAS PubMed Google Scholar
Haukka J, Niskanen L, Auvinen A (2017) Risk of cause-specific death in individuals with cancer—modifying role diabetes, statins and metformin. Int J Cancer 141:2437–2449
Article CAS PubMed Google Scholar
Cardwell CR, Hicks BM, Hughes C et al (2015) Statin use after diagnosis of breast cancer and survival: a population-based cohort study. Epidemiology 26:68–78
Mc Menamin ÚC, Murray LJ, Hughes CM et al (2016) Statin use and breast cancer survival: a nationwide cohort study in Scotland. BMC Cancer 16:1–11
Smith A, Murphy L, Sharp L et al (2016) De novo post-diagnosis statin use, breast cancer-specific and overall mortality in women with stage i–iii breast cancer. Br J Cancer 115:592–598
Article CAS PubMed PubMed Central Google Scholar
Bjarnadottir O, Feldt M, Inasu M et al (2020) Statin use, HMGCR expression, and breast cancer survival—the Malmö Diet and Cancer Study. Sci Rep 10:1–10
Brewer T, Masuda H, Liu D et al (2013) Statin use in primary inflammatory breast cancer: a cohort study. Br J Cancer 109:318–324
Article CAS PubMed PubMed Central Google Scholar
Desai P, Lehman A, Chlebowski RT et al (2015) Statins and breast cancer stage and mortality in the Women’s Health Initiative. Cancer Causes Control 26:529–539
Article PubMed PubMed Central Google Scholar
Nickels S, Vrieling A, Seibold P et al (2013) Mortality and recurrence risk in relation to the use of lipid-lowering drugs in a prospective breast cancer patient cohort. PLoS ONE 8:e75088
Article CAS PubMed PubMed Central Google Scholar
Botteri E, Munzone E, Rotmensz N et al (2013) Therapeutic effect of β-blockers in triple-negative breast cancer postmenopausal women. Breast Cancer Res Treat 140:567–575
Article CAS PubMed Google Scholar
Sim Y, Lim C, Phyu N et al (2022) The impact of statin use and breast cancer recurrence—a retrospective study in Singapore. Front Oncol 12:835320. https://doi.org/10.3389/fonc.2022.835320
Shaitelman SF, Stauder MC, Allen P et al (2017) Impact of statin use on outcomes in triple negative breast cancer. J Cancer 8:2026
Article PubMed PubMed Central Google Scholar
Ahern TP, Pedersen L, Tarp M et al (2011) Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study. J Natl Cancer Inst 103:1461–1468
Article CAS PubMed PubMed Central Google Scholar
Chae YK, Valsecchi ME, Kim J et al (2011) Reduced risk of breast cancer recurrence in patients using ACE inhibitors, ARBs, and/or statins. Cancer Invest 29:585–593
Article CAS PubMed Google Scholar
Lacerda L, Reddy JP, Liu D et al (2014) Simvastatin radiosensitizes differentiated and stem-like breast cancer cell lines and is associated with improved local control in inflammatory breast cancer patients treated with postmastectomy radiation. Stem Cells Transl Med 3:849–856
Article CAS PubMed PubMed Central Google Scholar
Inasu M, Feldt M, Jernström H et al (2022) Statin use and patterns of breast cancer recurrence in the Malmö Diet and Cancer Study. Breast 61:123–128. https://doi.org/10.1016/j.breast.2022.01.003
Kwan ML, Habel LA, Flick ED et al (2008) Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors. Breast Cancer Res Treat 109:573–579
Article CAS PubMed Google Scholar
Boudreau DM, Yu O, Chubak J et al (2014) Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer. Breast Cancer Res Treat 144:405–416
Article CAS PubMed PubMed Central Google Scholar
Sakellakis M, Akinosoglou K, Kostaki A et al (2016) Statins and risk of breast cancer recurrence. Breast Cancer: Targets Therapy 8:199
Harborg S, Heide-Jørgensen U, Ahern TP et al (2020) Statin use and breast cancer recurrence in postmenopausal women treated with adjuvant aromatase inhibitors: a Danish population-based cohort study. Breast Cancer Res Treat 183:153–160
Article CAS PubMed PubMed Central Google Scholar
Li YR, Ro V, Steel L et al (2019) Impact of long-term lipid-lowering therapy on clinical outcomes in breast cancer. Breast Cancer Res Treat 176:669–677
Tryggvadottir H, Huzell L, Gustbée E et al (2018) Interactions between ABCB1 genotype and preoperative statin use impact clinical outcomes among breast cancer patients. Front Oncol 428
Garwood ER, Kumar AS, Baehner FL et al (2010) Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer. Breast Cancer Res Treat 119:137–144
Article CAS PubMed PubMed Central Google Scholar
Bjarnadottir O, Rome
留言 (0)